Public list: Pharma Startups (4733)
Allon Therapeutics Inc. is a clinical-stage biotechnology company focused on developing the first drugs that impact the progression of neurodegernative diseases. Therapies available today treat only symptoms and have no effect on the course of the d...Show all
Company (Acquired)
San Diego, 92101
California, United States
| Total Funding | Date of Last Funding | |
|---|---|---|
| Allon Therapeutics | $2.5M | Sep 10, 2004 |
| Intarcia Therapeutics | $1513.7M | Apr 3, 2017 |
| Celera Genomics | $0M | May 17, 2011 |
| See all 15 competitors | ||
| Per Week | Per Month | Per 6 Months | Per Year | |
|---|---|---|---|---|
| Rank | Login to see details | |||
| Page Views Per Million | Login to see details | |||
| Page Views Per User | Login to see details | |||
| Reach Per Million | Login to see details | |||
| Investor | Investor Type | Location | Participating Rounds |
|---|
| Title | Application Date | Patent Date | Status (Patent / Application) |
|---|---|---|---|
| Neuroprotection using nap-like and sal-like peptide mimetics | Feb 18, 2010 | Dec 04, 2012 | Patent |
| Use of adnf polypeptides for treating peripheral neurotoxicity | Oct 03, 2008 | Mar 27, 2012 | Patent |
Download PDF